UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis

Journal of viral hepatitis, 2011-10, Vol.18 (10), p.e516-e522

2011

Volltextzugriff (PDF)

Determinants of long term survival and recurrence patterns after radiofrequency ablation for hepatocellular carcinoma developed on cirrhosis

Journal of hepatology, 2017, Vol.66 (1), p.S446-S446

2017

Volltextzugriff (PDF)

643 IMPROVED EFFICIENCY OF HCC SCREENING IS MAINLY DUE TO THE INTRODUCTION OF RFA AS THE FIRST LINE CURATIVE TREATMENT

Journal of hepatology, 2011-03, Vol.54, p.S260-S260

2011

Volltextzugriff (PDF)

181 TREATMENT BY RADIOFREQUENCY ABLATION FOLLOWED BY SALVAGE TRANSPLANTATION IN PATIENTS WITH CHILD PUGH A CIRRHOSIS AND HCC WITHIN MILAN CRITERIA

Journal of hepatology, 2010, Vol.52, p.S78-S78

2010

Volltextzugriff (PDF)

653 MULTIPOLAR RADIOFREQUENCY ABLATION FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA >5CM IN DIAMETER: TOLERANCE AND RESULTS AT 3 YEARS

Journal of hepatology, 2011-03, Vol.54, p.S264-S264

2011

Volltextzugriff (PDF)

652 MULTIPOLAR RADIOFREQUENCY ABLATION (MRFA) FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA (HCC) IN PATIENTS WITH CIRRHOSIS: PRELIMINARY EXPERIENCE IN 109 PATIENTS

Journal of hepatology, 2011-03, Vol.54, p.S263-S263

2011

Volltextzugriff (PDF)

Genetic dimorphism in superoxide dismutase and susceptibility to alcoholic cirrhosis, hepatocellular carcinoma, and death

Clinical gastroenterology and hepatology, 2005-03, Vol.3 (3), p.292-298

2005

Volltextzugriff (PDF)

P8 Le diabète est un facteur de risque indépendant de récidive à distance d’un carcinome hépato-cellulaire unique traité par radiofréquence chez des cirrhotiques Child Pugh A

Diabetes & metabolism, 2010, Vol.36, p.A41-A42

2010

Volltextzugriff (PDF)

PO13 Le traitement par metformine est associé à une réduction de l’incidence de carcinome hépatocellulaire chez les diabétiques atteints de cirrhose virale C

Diabetes & metabolism, 2010, Vol.36, p.A31-A31

2010

Volltextzugriff (PDF)

398 PREDICTIVE FACTORS OF HCC FREE SURVIVAL IN 203 PATIENTS WITH CIRRHOSIS CLASSED CHILD PUGH A AND HCC (≤ 5CM) TREATED BY RADIOFREQUENCY ABLATION (RFA)

Journal of hepatology, 2008, Vol.48, p.S154-S154

2008

Volltextzugriff (PDF)

397 LONG-TERM RESULTS OF RADIOFREQUENCY ABLATION (RFA) IN PATIENTS WITH CIRRHOSIS AND HCC ≤ 5 CM IN DIAMETER

Journal of hepatology, 2008, Vol.48, p.S154-S154

2008

Volltextzugriff (PDF)

947 FEASIBILITY AND PERFORMANCE OF THE LIVER STIFFNESS (LSM) MEASUREMENT FOR THE DIAGNOSIS OF FIBROSIS IN NAFLD

Journal of hepatology, 2008, Vol.48, p.S354-S355

2008

Volltextzugriff (PDF)

O23 Pronostic de la cirrhose virale C en fonction de l’insulino-résistance, la leptinémie et l’adiponectinémie

Diabetes & metabolism, 2010, Vol.36, p.A6-A7

2010

Volltextzugriff (PDF)

Percutaneous treatment of extrahepatic recurrence of hepatocellular carcinoma

Diagnostic and interventional imaging, 2016-11, Vol.97 (11), p.1117-1123

2016

Volltextzugriff (PDF)

Is hepatitis C virus NS3 protease quasispecies heterogeneity predictive of progression from cirrhosis to hepatocellular carcinoma?

Journal of viral hepatitis, 2007-02, Vol.14 (2), p.96-106

2007

Volltextzugriff (PDF)

FRI-074 - Determinants of long term survival and recurrence patterns after radiofrequency ablation for hepatocellular carcinoma developed on cirrhosis

Journal of hepatology, 2017, Vol.66 (1), p.S446-S446

2017

Volltextzugriff (PDF)

Sulfatase 2 Along with Syndecan 1 and Glypican 3 Serum Levels are Associated with a Prognostic Value in Patients with Alcoholic Cirrhosis-Related Advanced Hepatocellular Carcinoma

Journal of hepatocellular carcinoma, 2022, Vol.9, p.1369-1383

2022

Volltextzugriff (PDF)

Small solitary hepatocellular carcinoma (HCC) in child a cirrhosis: prognostic factors of survival in 142 patients

Journal of hepatology, 2001-04, Vol.34, p.93

Nkontchou, G

2001

Volltextzugriff (PDF)

Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis

British journal of cancer, 2006-01, Vol.94 (2), p.287-292

2006

Volltextzugriff (PDF)

1024 IDENTIFICATION OF SERUM PROTEOGLYCANS AS PROGNOSTIC BIOMARKERS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA AND ALCOHOLIC CIRRHOSIS

Journal of hepatology, 2012-04, Vol.56, p.S400-S401

2012

Volltextzugriff (PDF)

Preclinical and post-treatment changes in the HCC-associated serum proteome

British journal of cancer, 2006-11, Vol.95 (10), p.1379-1383

2006

Volltextzugriff (PDF)

1030 EPCAM EXPRESSION BY TUMOR CELLS IS AN INDEPENDENT PREDICTIVE FACTOR FOR DISTANT RECURRENCE IN UNINODULAR HEPATOCELLULAR CARCINOMA (≤5CM) TREATED BY RADIOFREQUENCY ABLATION

Journal of hepatology, 2011-03, Vol.54, p.S409-S409

2011

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(52)

Sprache

Englisch
(41)
Französisch
(11)

Erscheinungsjahr

n.n

Thema

Humans
(17)
Life Sciences & Biomedicine
(15)
Science & Technology
(15)
Female
(14)
Gastroenterology And Hepatology
(14)
Middle Aged
(14)
Male
(13)
Aged
(11)
Adult
(7)
Aged, 80 And Over
(7)
Gastroenterology & Hepatology
(7)
Hepatocellular Carcinoma
(7)
Biological And Medical Sciences
(6)
Gastroenterology. Liver. Pancreas. Abdomen
(6)
Liver. Biliary Tract. Portal Circulation. Exocrine Pancreas
(6)
Medical Sciences
(6)
Treatment Outcome
(6)
Retrospective Studies
(5)
Tumors
(5)
Carcinoma, Hepatocellular - Surgery
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis

Determinants of long term survival and recurrence patterns after radiofrequency ablation for hepatocellular carcinoma developed on cirrhosis

643 IMPROVED EFFICIENCY OF HCC SCREENING IS MAINLY DUE TO THE INTRODUCTION OF RFA AS THE FIRST LINE CURATIVE TREATMENT

181 TREATMENT BY RADIOFREQUENCY ABLATION FOLLOWED BY SALVAGE TRANSPLANTATION IN PATIENTS WITH CHILD PUGH A CIRRHOSIS AND HCC WITHIN MILAN CRITERIA

A 2-year multicenter, double-blind, randomized, placebo-controlled study of bezafibrate for the treatment of primary biliary cholangitis in patients with inadequate biochemical response to ursodeoxycholic acid therapy (Bezurso)

A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis

653 MULTIPOLAR RADIOFREQUENCY ABLATION FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA >5CM IN DIAMETER: TOLERANCE AND RESULTS AT 3 YEARS

652 MULTIPOLAR RADIOFREQUENCY ABLATION (MRFA) FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA (HCC) IN PATIENTS WITH CIRRHOSIS: PRELIMINARY EXPERIENCE IN 109 PATIENTS

Genetic dimorphism in superoxide dismutase and susceptibility to alcoholic cirrhosis, hepatocellular carcinoma, and death

P8 Le diabète est un facteur de risque indépendant de récidive à distance d’un carcinome hépato-cellulaire unique traité par radiofréquence chez des cirrhotiques Child Pugh A

PO13 Le traitement par metformine est associé à une réduction de l’incidence de carcinome hépatocellulaire chez les diabétiques atteints de cirrhose virale C

398 PREDICTIVE FACTORS OF HCC FREE SURVIVAL IN 203 PATIENTS WITH CIRRHOSIS CLASSED CHILD PUGH A AND HCC (≤ 5CM) TREATED BY RADIOFREQUENCY ABLATION (RFA)

397 LONG-TERM RESULTS OF RADIOFREQUENCY ABLATION (RFA) IN PATIENTS WITH CIRRHOSIS AND HCC ≤ 5 CM IN DIAMETER

947 FEASIBILITY AND PERFORMANCE OF THE LIVER STIFFNESS (LSM) MEASUREMENT FOR THE DIAGNOSIS OF FIBROSIS IN NAFLD

O23 Pronostic de la cirrhose virale C en fonction de l’insulino-résistance, la leptinémie et l’adiponectinémie

Percutaneous treatment of extrahepatic recurrence of hepatocellular carcinoma

Is hepatitis C virus NS3 protease quasispecies heterogeneity predictive of progression from cirrhosis to hepatocellular carcinoma?

FRI-074 - Determinants of long term survival and recurrence patterns after radiofrequency ablation for hepatocellular carcinoma developed on cirrhosis

Sulfatase 2 Along with Syndecan 1 and Glypican 3 Serum Levels are Associated with a Prognostic Value in Patients with Alcoholic Cirrhosis-Related Advanced Hepatocellular Carcinoma

LBO-01 - A 2-year multicenter, double-blind, randomized, placebo-controlled study of bezafibrate for the treatment of primary biliary cholangitis in patients with inadequate biochemical response to ursodeoxycholic acid therapy (Bezurso)

Small solitary hepatocellular carcinoma (HCC) in child a cirrhosis: prognostic factors of survival in 142 patients

Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis

1024 IDENTIFICATION OF SERUM PROTEOGLYCANS AS PROGNOSTIC BIOMARKERS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA AND ALCOHOLIC CIRRHOSIS

Preclinical and post-treatment changes in the HCC-associated serum proteome

1030 EPCAM EXPRESSION BY TUMOR CELLS IS AN INDEPENDENT PREDICTIVE FACTOR FOR DISTANT RECURRENCE IN UNINODULAR HEPATOCELLULAR CARCINOMA (≤5CM) TREATED BY RADIOFREQUENCY ABLATION

Suchergebnisse filtern